NCT02302222

Brief Summary

The goal of this study is to evaluate the impact of Customizable in the management of extensive closed surgical incisions for Subjects undergoing abdominal surgery for incisional hernia repair and/or functional panniculectomy as compared to SOC dressing, and to significantly reduce the SSC rate experienced by Subjects receiving Customizable vs. SOC surgical incision dressing.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2015

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 26, 2014

Completed
5 months until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2017

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

December 12, 2018

Completed
Last Updated

October 16, 2024

Status Verified

October 1, 2024

Enrollment Period

2.3 years

First QC Date

November 24, 2014

Results QC Date

July 11, 2018

Last Update Submit

October 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Surgical Site Complications

    Surgical Site Complications: * Dehiscence * Surgical site infection (SSI)

    Within 30 Days Post-Surgical Procedure

Study Arms (2)

Standard of Care

ACTIVE COMPARATOR

dry sterile dressing/gauze and steristrips

Device: Standard of Care Dressing

Customizable

EXPERIMENTAL

Prevena Customizable Dressing with ActiV.A.C. Therapy Unit

Device: Customizable Dressing with ActiV.A.C. Therapy Unit

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • an adult 18 years old or older of either gender
  • able to provide their own informed consent
  • will undergo:
  • a functional panniculectomy with a transverse or a fleur-de-lis incision
  • AND/OR -
  • an incisional hernia repair with a vertical incision at least 20 cm in length and at least 10 cm of undermining on each side of the incision
  • BMI equal to or greater than 30
  • has maintained a stable weight for at least 3 months as determined by the Investigator (applies to post weight loss patients only)
  • pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:
  • Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital or uninfected urinary tract is not entered
  • OR -
  • Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital or uninfected urinary tract are entered under controlled conditions and without unusual contamination
  • willing and able to return for all scheduled study visits
  • if a female of child-bearing potential, must test negative on a urine pregnancy test
  • if a female of child-bearing potential, must be willing to utilize an acceptable method of birth control (i.e. oral contraceptives, condom with spermicide, diaphragm with spermicide, implants, IUD, injections, vaginal rings, hormonal skin patch) for the duration of the study
  • +1 more criteria

You may not qualify if:

  • has a systemic bacterial or fungal infection at the time of surgery for incisional hernia repair and/or functional panniculectomy
  • has a remote-site skin infection at the time of surgery for incisional hernia repair or functional panniculectomy
  • pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:
  • Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
  • OR -
  • Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
  • will have a transverse or fleur-de-lis incision that extends beyond the flank area and requires moving the Subject from the supine position during surgery
  • has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives
  • has participated in a clinical study within the past 30 days
  • who, in the investigator's opinion, would have any clinically significant condition that would impair the Subject's ability to comply with the study procedures
  • determined to have a CDC Wound Classification of:
  • Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
  • OR -
  • Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Medical Research Center

Miami, Florida, 33144, United States

Location

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

Location

Limitations and Caveats

The study was terminated after an interim data review as the SSC rates were outside the ranges of the sample size assumptions used for the study design.

Results Point of Contact

Title
Sr Director, Global Clinical Development
Organization
Acelity

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
GT60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2014

First Posted

November 26, 2014

Study Start

May 1, 2015

Primary Completion

July 31, 2017

Study Completion

July 31, 2017

Last Updated

October 16, 2024

Results First Posted

December 12, 2018

Record last verified: 2024-10

Locations